Publications
- Primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia: A prospective pilot trial using PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure2007 | Publication without faculty affiliation
- Rationalization of therapeutic LDL-apheresis procedure with analysis of primary hemostasis application of PFA-100 analysis and modified platelets aggregation2006 | Publication without faculty affiliation
- The Impact of Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies with and without Apheresis on Platelet Aggregation in Familial Hypercholesterolemia2024 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- The Effect of 4-Methylcatechol on Platelets in Familial Hypercholesterolemic Patients Treated with Lipid Apheresis and/or Proprotein Convertase Subtilisin Kexin 9 Monoclonal Antibodies2023 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Rheoferéza v léčbě věkem podmíněné makulární degenerace2023 | Faculty of Medicine in Hradec Králové
- Hypolipidemic therapy in pregnant women with homozygous familial hypercholesterolemia2022 | Faculty of Medicine in Hradec Králov é
- Pregnancy in homozygous familial hypercholesterolemia-A case series2022 | Faculty of Medicine in Hradec Králové
- Multiplex Protein Biomarker Profiling in Patients with Familial Hypercholesterolemia2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Science
- Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients2021 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
Loading network view...